Speaker illustration

Professor Finn Olav Levy

University of Oslo, Oslo (Norway)

HFWM: Complex effects of the myosin activator omecamtiv mecarbil on cardiac contractility

Event: HEART FAILURE 2016

Topic: Drug therapy, other

Session: Basic Science: Drug therapy, other

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb